100102 Whether direct or indirect, GLP-1R agonists seem to favorably impact the metabolic function of VAT by reducing macrophage infiltration into adipose tissue and suppressing expression of proinflammatory genes
Ruff CT, Baron M, Im K, ODonoghue ML, Fiedorek FT, Sabatine MS
Retatrutide is an investigational triple receptor agonist targeting GLP-1, GIP, and glucagon receptors not yet approved by the MHRA or EMA as of April 2025
Electrolyte disturbances represent another important consideration
What Is the Wegovy Pill, and How Does It Work
This article is based on Innovas GLP-1 Drugs Are Changing the Consumer Food Landscape Globally report